Ticker Scorecard - OMGA Basics Company: Omega Therapeutics, Inc. IPO Date: June 30, 2021 Sector: Healthcare Industry: Biotech Market Cap: $8.85M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 5.29% Avg Daily Range (30 D): $0.04 | 11.51% Avg Daily Range (90 D): $0.05 | 7.29% Institutional Daily Volume Avg Daily Volume: .77M Avg Daily Volume (30 D): 14.78M Avg Daily Volume (90 D): 5.21M Trade Size Avg Trade Size (Sh.): 315 Avg Trade Size (Sh.) (30 D): 1,145 Avg Trade Size (Sh.) (90 D): 1,039 Institutional Trades Total Inst.Trades: 34 Avg Inst. Trade: $2.47M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.55M Avg Closing Trade (30 D): $4.47M Avg Closing Trade (90 D): $4.47M Avg Closing Volume: 510.65K     News Sep 17, 2024 @ 11:00 AM Omega Therapeutics Announces Publication of Epigen... Source: N/A Jun 24, 2024 @ 11:00 AM Omega Therapeutics Announces Election of Richard N... Source: Omega Therapeutics Jun 19, 2024 @ 9:05 AM Nurix Therapeutics (NRIX) Surges 20.6%: Is This an... Source: Zacks Equity Research May 30, 2024 @ 11:00 AM Omega Therapeutics To Participate In Two Upcoming ... Source: Omega Therapeutics May 29, 2024 @ 11:00 AM Omega Therapeutics Appoints Kaan Certel, Ph.D., as... Source: Omega Therapeutics Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.32 $-.3 $-.3 Diluted EPS $-1.32 $-.3 $-.3 Revenue $ 8.1M $ 2.61M $ 2.13M Gross Profit $ $ $ Net Income / Loss $ -73.09M $ -16.44M $ -16.31M Operating Income / Loss $ -74.15M $ -16.42M $ -16.58M Cost of Revenue $ $ $ Net Cash Flow $ -51.39M $ -15.48M $ -14.18M PE Ratio